US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist
  • 11.770
  • +0.570+5.09%
Close Jul 22 16:00 ET
  • 11.970
  • +0.200+1.70%
Post 16:22 ET
646.33MMarket Cap-4904P/E (TTM)

Astria Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-44.07%-19.09M
-57.23%-68.45M
-183.55%-30.24M
-39.12%-14.26M
-6.31%-10.7M
-5.53%-13.25M
-44.38%-43.53M
-69.65%-10.66M
-32.26%-10.25M
-35.96%-10.06M
Net income from continuing operations
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.69%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
-52.42%-12M
-50.70%-11.25M
Operating gains losses
----
----
----
----
----
----
2,071.83%1.54M
--0
--0
--0
Other non cash items
-541.38%-512K
223.30%545K
128.65%163K
231.25%159K
-32.28%107K
246.84%116K
-100.27%-442K
-198.44%-569K
860.00%48K
2,533.33%158K
Change In working capital
58.60%-1.41M
-191.16%-2.41M
-150.60%-1.06M
196.51%1.62M
608.24%432K
-3,796.74%-3.4M
168.27%2.65M
65.09%2.1M
142.64%545K
57.29%-85K
-Change in prepaid assets
-7.64%-930K
-189.92%-4.55M
-193.45%-3.23M
-61.13%-1.12M
983.61%661K
-630.06%-864K
-1,944.71%-1.57M
-193.46%-1.1M
66.91%-692K
-73.71%61K
-Change in payables and accrued expense
86.75%-317K
-24.66%2.74M
-12.02%2.33M
144.16%2.89M
40.00%-78K
-4,171.43%-2.39M
210.97%3.64M
290.69%2.65M
43.45%1.18M
68.97%-130K
-Change in other current liabilities
-11.03%-161K
-206.27%-610K
-128.91%-159K
-381.82%-155K
-843.75%-151K
-866.67%-145K
184.29%574K
--550K
--55K
---16K
Cash from discontinued investing activities
Operating cash flow
-44.07%-19.09M
-57.23%-68.45M
-183.55%-30.24M
-39.12%-14.26M
-6.31%-10.7M
-5.53%-13.25M
-44.38%-43.53M
-69.65%-10.66M
-32.26%-10.25M
-35.96%-10.06M
Investing cash flow
Cash flow from continuing investing activities
-164.74%-126.23M
180.81%135.05M
98.51%-2.02M
-100.21%-4K
-751.76%-57.92M
819.55%194.99M
-1,231.17%-167.13M
-246.62%-135.18M
1.95M
-6.8M
Net PPE purchase and sale
--0
72.53%-25K
48.39%-16K
93.10%-4K
--0
---5K
-333.33%-91K
---31K
---58K
---2K
Net investment purchase and sale
-164.73%-126.23M
180.87%135.08M
98.52%-2M
--0
-752.02%-57.92M
819.57%195M
-779.15%-167.04M
-246.54%-135.15M
--2.01M
---6.8M
Cash from discontinued investing activities
Investing cash flow
-164.74%-126.23M
180.81%135.05M
98.51%-2.02M
-100.21%-4K
-751.76%-57.92M
819.55%194.99M
-1,231.17%-167.13M
-246.62%-135.18M
--1.95M
---6.8M
Financing cash flow
Cash flow from continuing financing activities
383,162.16%141.81M
-38.92%88.4M
-26.93%87.98M
-99.55%110K
273K
37K
38.78%144.72M
708,117.65%120.4M
405,300.00%24.32M
0
Net common stock issuance
--137.17M
-39.17%87.98M
-26.90%87.98M
----
----
--0
38.73%144.64M
--120.35M
----
----
Proceeds from stock option exercised by employees
12,421.62%4.63M
400.00%420K
--0
223.53%110K
--273K
--37K
265.22%84K
194.12%50K
--34K
--0
Cash from discontinued financing activities
Financing cash flow
383,162.16%141.81M
-38.92%88.4M
-26.93%87.98M
-99.55%110K
--273K
--37K
38.78%144.72M
708,117.65%120.4M
405,300.00%24.32M
--0
Net cash flow
Beginning cash position
749.25%175.69M
-76.12%20.69M
160.04%119.97M
345.44%134.12M
331.04%202.46M
-76.12%20.69M
245.81%86.63M
-65.02%46.14M
-78.44%30.11M
-68.06%46.97M
Current changes in cash
-101.94%-3.52M
335.07%155.01M
318.98%55.72M
-188.31%-14.15M
-305.33%-68.34M
558.36%181.78M
-207.09%-65.94M
43.79%-25.45M
306.96%16.03M
-127.85%-16.86M
End cash Position
-14.96%172.18M
749.25%175.69M
749.25%175.69M
160.04%119.97M
345.44%134.12M
331.04%202.46M
-76.12%20.69M
-76.12%20.69M
-65.02%46.14M
-78.44%30.11M
Free cash flow
-44.02%-19.09M
-56.95%-68.47M
-182.88%-30.25M
-38.37%-14.26M
-6.29%-10.7M
-5.57%-13.26M
-44.58%-43.62M
-70.14%-10.7M
-33.01%-10.31M
-35.99%-10.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -44.07%-19.09M-57.23%-68.45M-183.55%-30.24M-39.12%-14.26M-6.31%-10.7M-5.53%-13.25M-44.38%-43.53M-69.65%-10.66M-32.26%-10.25M-35.96%-10.06M
Net income from continuing operations -78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.69%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M-52.42%-12M-50.70%-11.25M
Operating gains losses ------------------------2,071.83%1.54M--0--0--0
Other non cash items -541.38%-512K223.30%545K128.65%163K231.25%159K-32.28%107K246.84%116K-100.27%-442K-198.44%-569K860.00%48K2,533.33%158K
Change In working capital 58.60%-1.41M-191.16%-2.41M-150.60%-1.06M196.51%1.62M608.24%432K-3,796.74%-3.4M168.27%2.65M65.09%2.1M142.64%545K57.29%-85K
-Change in prepaid assets -7.64%-930K-189.92%-4.55M-193.45%-3.23M-61.13%-1.12M983.61%661K-630.06%-864K-1,944.71%-1.57M-193.46%-1.1M66.91%-692K-73.71%61K
-Change in payables and accrued expense 86.75%-317K-24.66%2.74M-12.02%2.33M144.16%2.89M40.00%-78K-4,171.43%-2.39M210.97%3.64M290.69%2.65M43.45%1.18M68.97%-130K
-Change in other current liabilities -11.03%-161K-206.27%-610K-128.91%-159K-381.82%-155K-843.75%-151K-866.67%-145K184.29%574K--550K--55K---16K
Cash from discontinued investing activities
Operating cash flow -44.07%-19.09M-57.23%-68.45M-183.55%-30.24M-39.12%-14.26M-6.31%-10.7M-5.53%-13.25M-44.38%-43.53M-69.65%-10.66M-32.26%-10.25M-35.96%-10.06M
Investing cash flow
Cash flow from continuing investing activities -164.74%-126.23M180.81%135.05M98.51%-2.02M-100.21%-4K-751.76%-57.92M819.55%194.99M-1,231.17%-167.13M-246.62%-135.18M1.95M-6.8M
Net PPE purchase and sale --072.53%-25K48.39%-16K93.10%-4K--0---5K-333.33%-91K---31K---58K---2K
Net investment purchase and sale -164.73%-126.23M180.87%135.08M98.52%-2M--0-752.02%-57.92M819.57%195M-779.15%-167.04M-246.54%-135.15M--2.01M---6.8M
Cash from discontinued investing activities
Investing cash flow -164.74%-126.23M180.81%135.05M98.51%-2.02M-100.21%-4K-751.76%-57.92M819.55%194.99M-1,231.17%-167.13M-246.62%-135.18M--1.95M---6.8M
Financing cash flow
Cash flow from continuing financing activities 383,162.16%141.81M-38.92%88.4M-26.93%87.98M-99.55%110K273K37K38.78%144.72M708,117.65%120.4M405,300.00%24.32M0
Net common stock issuance --137.17M-39.17%87.98M-26.90%87.98M----------038.73%144.64M--120.35M--------
Proceeds from stock option exercised by employees 12,421.62%4.63M400.00%420K--0223.53%110K--273K--37K265.22%84K194.12%50K--34K--0
Cash from discontinued financing activities
Financing cash flow 383,162.16%141.81M-38.92%88.4M-26.93%87.98M-99.55%110K--273K--37K38.78%144.72M708,117.65%120.4M405,300.00%24.32M--0
Net cash flow
Beginning cash position 749.25%175.69M-76.12%20.69M160.04%119.97M345.44%134.12M331.04%202.46M-76.12%20.69M245.81%86.63M-65.02%46.14M-78.44%30.11M-68.06%46.97M
Current changes in cash -101.94%-3.52M335.07%155.01M318.98%55.72M-188.31%-14.15M-305.33%-68.34M558.36%181.78M-207.09%-65.94M43.79%-25.45M306.96%16.03M-127.85%-16.86M
End cash Position -14.96%172.18M749.25%175.69M749.25%175.69M160.04%119.97M345.44%134.12M331.04%202.46M-76.12%20.69M-76.12%20.69M-65.02%46.14M-78.44%30.11M
Free cash flow -44.02%-19.09M-56.95%-68.47M-182.88%-30.25M-38.37%-14.26M-6.29%-10.7M-5.57%-13.26M-44.58%-43.62M-70.14%-10.7M-33.01%-10.31M-35.99%-10.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg